Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-023863

EVP, Chief Financial Officer sold 1,916 shares at $18.16 ($34,795)

  • EVP, Chief Financial Officer acquired 5,275 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schneyer Mark C. EVP, Chief Financial Officer 2023-04-05 Option exercise +5,275 9,393 D
Schneyer Mark C. EVP, Chief Financial Officer 2023-04-06 Sale −1,916 $18.16 $34,795 7,477 D
Derivatives
Schneyer Mark C. EVP, Chief Financial Officer 2023-04-05 Option exercise · Restricted Stock Units −5,275 15,826 D
Open-market sales · 1,916 sh · avg $18.16 · $34,795
Loading xslF345X04/doc4.xml…